Digital
April 2026 | PM-GB-RS-WCNT-260004 (V1.0)
Digital Desktop COPD Action Planner
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Digital
April 2026 | PM-GB-RS-WCNT-260005 (V1.0)
Digital Desktop COPD Symptom Tracker
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Digital
April 2026 | PM-GB-RS-WCNT-260003 (V1.0)
Digital Mobile COPD Action Planner
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Digital
April 2026 | PM-GB-RS-WCNT-260006 (V1.0)
Digital Mobile COPD Symptom Tracker
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Physical
May 2026 | PM-GB-RS-WCNT-200028 (v3.0)
Ellipta demonstration device
Demonstration device for healthcare professionals to show patients how to use the Ellipta device correctly.
Physical
May 2026 | PM-GB-RS-WCNT-200035 (v4.0)
Ellipta Inhalation Trainer
Training whistle that helps patients understand the correct inspiratory flow needed to use the Ellipta device.
Physical
July 2026 | PM-GB-MPL-WCNT-260013
Nucala (mepolizumab) for COPD: Patient information booklet
For patients with COPD, prescribed Nucala 100 mg prefilled syringe/pen.
Digital
July 2026 | PM-GB-MPL-WCNT-260016
Nucala (mepolizumab) for COPD: Patient information booklet (Digital)
For patients with COPD, prescribed Nucala 100 mg prefilled syringe/pen.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellowcard in the Google Play or Apple App Store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com.